Vector BioMed
- Business Model
- B2B
- Website
- vectorbiomed.com
- Total Funding
- $15.0M
- Last Round
- $15.0M SeedJan 2023
- Rounds
- 1
About
CDMO providing research and commercial-scale manufacturing services for lentivirus products.
Summary
Vector BioMed is a Biotech company. It has raised $15.0M in total across 1 round, most recently a $15.0M Seed round in Jan 2023. Investors include Viking Global and Casdin Capital.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.